Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-30 @ 8:29 AM
Study NCT ID:
NCT01413503
Status:
COMPLETED
Last Update Posted:
2018-09-18
First Post:
2011-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1991-05
Start Date Type:
None
Primary Completion Date:
2007-09-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-08
First Submit QC Date:
None
Study First Post Date:
2011-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-23
Results First Submit QC Date:
None
Results First Post Date:
2018-09-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-23
Last Update Post Date:
2018-09-18
Last Update Post Date Type:
ACTUAL